Prosonix is an innovative speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design
Latest News
Sep 11, 2014
Prosonix Confirms the Potential of its Multi-Component Particle™ Technology for Developing Novel...
Sep 2, 2014
Prosonix’ Marketing Authorisation Application for PSX1001 – a Generic Version of...
May 15, 2014
Prosonix to Present Results of Phase 2 Study of PSX1002 in COPD at ATS Meeting
10-12 Dec 2014
Edinburgh, Scotland, UK
5-8 May 2015
Nice, France
Terms & Conditions
© Prosonix Ltd, 2013
The Magdalen Centre   Robert Robinson Avenue   Oxford Science Park   Oxford   OX4 4GA   United Kingdom   |   Tel: +44 (0)1865 784250   |   Email: Here